269 related articles for article (PubMed ID: 21630604)
1. Patient adherence to oral anticancer drugs: an emerging issue in modern oncology.
Foulon V; Schöffski P; Wolter P
Acta Clin Belg; 2011; 66(2):85-96. PubMed ID: 21630604
[TBL] [Abstract][Full Text] [Related]
2. Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review.
Verbrugghe M; Verhaeghe S; Lauwaert K; Beeckman D; Van Hecke A
Cancer Treat Rev; 2013 Oct; 39(6):610-21. PubMed ID: 23428230
[TBL] [Abstract][Full Text] [Related]
3. Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice.
Holle LM; Puri S; Clement JM
J Oncol Pharm Pract; 2016 Jun; 22(3):511-6. PubMed ID: 25900102
[TBL] [Abstract][Full Text] [Related]
4. Adherence to oral cancer therapies: nursing interventions.
Winkeljohn D
Clin J Oncol Nurs; 2010 Aug; 14(4):461-6. PubMed ID: 20682501
[TBL] [Abstract][Full Text] [Related]
5. Anticancer oral therapy: emerging related issues.
Banna GL; Collovà E; Gebbia V; Lipari H; Giuffrida P; Cavallaro S; Condorelli R; Buscarino C; Tralongo P; Ferraù F
Cancer Treat Rev; 2010 Dec; 36(8):595-605. PubMed ID: 20570443
[TBL] [Abstract][Full Text] [Related]
6. Patient adherence and persistence with oral anticancer treatment.
Ruddy K; Mayer E; Partridge A
CA Cancer J Clin; 2009; 59(1):56-66. PubMed ID: 19147869
[TBL] [Abstract][Full Text] [Related]
7. Adherence and patients' experiences with the use of oral anticancer agents.
Timmers L; Boons CC; Kropff F; van de Ven PM; Swart EL; Smit EF; Zweegman S; Kroep JR; Timmer-Bonte JN; Boven E; Hugtenburg JG
Acta Oncol; 2014 Feb; 53(2):259-67. PubMed ID: 24266637
[TBL] [Abstract][Full Text] [Related]
8. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
Divakaruni A; Saylor E; Duffy AP
J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
[TBL] [Abstract][Full Text] [Related]
9. Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents.
Gebbia V; Bellavia G; Ferraù F; Valerio MR
Expert Opin Drug Saf; 2012 May; 11 Suppl 1():S49-59. PubMed ID: 22149481
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of antineoplastic agents: the challenges for healthcare professionals.
Tadic D; Spasojevic IB; Tomasevic ZI; Dejanovic SD
J BUON; 2015; 20(3):690-8. PubMed ID: 26214619
[TBL] [Abstract][Full Text] [Related]
11. [Novel oral anticancer drugs: a review of adverse drug reactions, interactions and patient adherence].
Bartal A; Mátrai Z; Szucs A; Belinszkaja G; Langmár Z; Rosta A
Orv Hetil; 2012 Jan; 153(2):66-78. PubMed ID: 22217686
[TBL] [Abstract][Full Text] [Related]
12. A review on adherence management in patients on oral cancer therapies.
Wood L
Eur J Oncol Nurs; 2012 Sep; 16(4):432-8. PubMed ID: 22051845
[TBL] [Abstract][Full Text] [Related]
13. Extending the quality and safety agenda from parenteral to oral chemotherapy.
Krzyzanowska MK; Powis M
J Oncol Pract; 2015 May; 11(3):198-201. PubMed ID: 25829521
[No Abstract] [Full Text] [Related]
14. Adherence to oral antineoplastic agents by cancer patients: definition and literature review.
Bassan F; Peter F; Houbre B; Brennstuhl MJ; Costantini M; Speyer E; Tarquinio C
Eur J Cancer Care (Engl); 2014 Jan; 23(1):22-35. PubMed ID: 24079854
[TBL] [Abstract][Full Text] [Related]
15. Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer.
Sommers RM; Miller K; Berry DL
Oncol Nurs Forum; 2012 Jul; 39(4):E373-9. PubMed ID: 22750908
[TBL] [Abstract][Full Text] [Related]
16. Overview of the challenges related to oral agents for cancer and their impact on adherence.
Tipton JM
Clin J Oncol Nurs; 2015 Jun; 19(3 Suppl):37-40. PubMed ID: 26030391
[TBL] [Abstract][Full Text] [Related]
17. A Structured Nursing Intervention to Address Oral Chemotherapy Adherence in Patients With Non-Small Cell Lung Cancer.
Boucher J; Lucca J; Hooper C; Pedulla L; Berry DL
Oncol Nurs Forum; 2015 Jul; 42(4):383-9. PubMed ID: 26148317
[TBL] [Abstract][Full Text] [Related]
18. [The importance of adherence to oral therapies in the field of oncology: the example of breast cancer].
Huiart L; Bardou VJ; Giorgi R
Bull Cancer; 2013 Oct; 100(10):1007-15. PubMed ID: 24113516
[TBL] [Abstract][Full Text] [Related]
19. [Acceptance of an oncologic addendum for the application of the German Standardized Medication Plan in oral anticancer drug therapy].
Barnert AK; Hofmann P; Liekweg A; Kunze A; Scheid C; Hermes-Moll K; Osburg S; Jaehde U
Z Evid Fortbild Qual Gesundhwes; 2022 Dec; 175():29-42. PubMed ID: 36372643
[TBL] [Abstract][Full Text] [Related]
20. [ADHERENCE TO ORAL ANTI-CANCER DRUGS IN HEMATO-ONCOLOGY].
Ashkenazi S; Dreyer J; Raanani P; Leader A
Harefuah; 2017 Apr; 156(4):254-258. PubMed ID: 28551924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
